• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类代谢组中 SARS-CoV-2 主蛋白酶活性位点配体。

SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome.

机构信息

Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", Piazza G. Cesare 11, 70124 Bari, Italy.

Department of Medicine, University Campus Bio-Medico of Rome, Via Alvaro del Portillo 21, 00128 Rome, Italy.

出版信息

Molecules. 2021 Mar 5;26(5):1409. doi: 10.3390/molecules26051409.

DOI:10.3390/molecules26051409
PMID:33807773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7961382/
Abstract

In late 2019, a global pandemic occurred. The causative agent was identified as a member of the family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, we present an analysis on the substances identified in the human metabolome capable of binding the active site of the SARS-CoV-2 main protease (M). The substances present in the human metabolome have both endogenous and exogenous origins. The aim of this research was to find molecules whose biochemical and toxicological profile was known that could be the starting point for the development of antiviral therapies. Our analysis revealed numerous metabolites-including xenobiotics-that bind this protease, which are essential to the lifecycle of the virus. Among these substances, silybin, a flavolignan compound and the main active component of silymarin, is particularly noteworthy. Silymarin is a standardized extract of milk thistle, , and has been shown to exhibit antioxidant, hepatoprotective, antineoplastic, and antiviral activities. Our results-obtained in silico and in vitro-prove that silybin and silymarin, respectively, are able to inhibit M, representing a possible food-derived natural compound that is useful as a therapeutic strategy against COVID-19.

摘要

2019 年末,一场全球大流行疫情发生。病原体被确定为冠状病毒科的一个成员,称为严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)。在这项研究中,我们对人类代谢组中能够结合 SARS-CoV-2 主要蛋白酶(M)活性位点的物质进行了分析。人类代谢组中的物质既有内源性的,也有外源性的。本研究的目的是找到已知生化和毒理学特征的分子,作为抗病毒治疗发展的起点。我们的分析揭示了许多代谢物,包括结合这种蛋白酶的外来物质,这些物质对病毒的生命周期至关重要。在这些物质中,水飞蓟宾是一种黄酮类化合物,是水飞蓟素的主要活性成分,尤其值得注意。水飞蓟素是奶蓟草的标准化提取物,已被证明具有抗氧化、保肝、抗肿瘤和抗病毒活性。我们的体内和体外研究结果证明,水飞蓟宾和水飞蓟素分别能够抑制 M,这代表了一种可能的源自食物的天然化合物,可作为对抗 COVID-19 的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/191fefb8fba7/molecules-26-01409-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/ef5be63319be/molecules-26-01409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/5f6cad05e561/molecules-26-01409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/611d66791194/molecules-26-01409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/d4c7362a90fe/molecules-26-01409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/191fefb8fba7/molecules-26-01409-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/ef5be63319be/molecules-26-01409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/5f6cad05e561/molecules-26-01409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/611d66791194/molecules-26-01409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/d4c7362a90fe/molecules-26-01409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e0/7961382/191fefb8fba7/molecules-26-01409-g005.jpg

相似文献

1
SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome.人类代谢组中 SARS-CoV-2 主蛋白酶活性位点配体。
Molecules. 2021 Mar 5;26(5):1409. doi: 10.3390/molecules26051409.
2
Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug.用于药物再利用的 SARS-CoV-2 主要蛋白酶抑制剂的系统搜索:依他尼酸作为一种潜在药物。
Viruses. 2021 Jan 13;13(1):106. doi: 10.3390/v13010106.
3
Conserved interactions required for inhibition of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).抑制严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 主蛋白酶所需的保守相互作用。
Sci Rep. 2020 Nov 30;10(1):20808. doi: 10.1038/s41598-020-77794-5.
4
In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease.基于有机三唑的配体作为严重急性呼吸综合征冠状病毒2主蛋白酶潜在抑制性药物化合物的计算机模拟鉴定与验证
Molecules. 2021 Oct 14;26(20):6199. doi: 10.3390/molecules26206199.
5
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M Protease.利用定量构效关系、对接和分子动力学对严重急性呼吸综合征冠状病毒2 M蛋白酶的潜在抑制剂进行药物再利用研究
Molecules. 2020 Nov 6;25(21):5172. doi: 10.3390/molecules25215172.
6
In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.计算机模拟研究评估新型冠状病毒(COVID-19)和 SARS-CoV 的 3C 样蛋白酶的新型结构的抗病毒活性。
Med Chem. 2021;17(4):380-395. doi: 10.2174/1573396316999200727125522.
7
An Updated Review on SARS-CoV-2 Main Proteinase (M): Protein Structure and Small-Molecule Inhibitors.SARS-CoV-2 主要蛋白酶(M)的最新综述:蛋白质结构和小分子抑制剂。
Curr Top Med Chem. 2021;21(6):442-460. doi: 10.2174/1568026620666201207095117.
8
Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19.基于结构的新型地衣化合物筛选对 SARS 冠状病毒主蛋白酶(Mpro)作为 COVID-19 的潜在抑制剂。
Mol Divers. 2021 Aug;25(3):1665-1677. doi: 10.1007/s11030-020-10118-x. Epub 2020 Jun 29.
9
Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2.主动学习和神经网络的潜力加速了针对 SARS-CoV-2 的新型有效分子设计的分子筛选。
Biomed Res Int. 2021 May 25;2021:6696012. doi: 10.1155/2021/6696012. eCollection 2021.
10
An automated positive selection screen in yeast provides support for boron-containing compounds as inhibitors of SARS-CoV-2 main protease.酵母中的自动正向筛选实验为含硼化合物作为 SARS-CoV-2 主蛋白酶抑制剂提供了支持。
Microbiol Spectr. 2024 Oct 3;12(10):e0124924. doi: 10.1128/spectrum.01249-24. Epub 2024 Aug 20.

引用本文的文献

1
Accurate Prediction of Drug Activity by Computational Methods: Importance of Thermal Capacity.通过计算方法准确预测药物活性:热容量的重要性。
Molecules. 2025 Jun 12;30(12):2563. doi: 10.3390/molecules30122563.
2
The Dynamics of OXA-23 β-Lactamase from .OXA-23 β-内酰胺酶的动力学研究。
Int J Mol Sci. 2023 Dec 15;24(24):17527. doi: 10.3390/ijms242417527.
3
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors.评估计算机模拟研究在发现与各种 SARS-CoV-2 受体相互作用的药物候选物方面的潜在贡献。

本文引用的文献

1
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.SARS-CoV-2 从高中和性的 COVID-19 恢复期血浆中逃逸。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2103154118.
2
Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug.用于药物再利用的 SARS-CoV-2 主要蛋白酶抑制剂的系统搜索:依他尼酸作为一种潜在药物。
Viruses. 2021 Jan 13;13(1):106. doi: 10.3390/v13010106.
3
Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches.
Int J Mol Sci. 2023 Oct 24;24(21):15518. doi: 10.3390/ijms242115518.
4
Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid Cancer.基于网络药理学分析和实验验证水飞蓟宾对甲状腺乳头状癌细胞增殖、迁移和免疫治疗的作用
Endocr Metab Immune Disord Drug Targets. 2024;24(6):672-690. doi: 10.2174/0118715303248000230922185110.
5
AI-Aided Search for New HIV-1 Protease Ligands.人工智能辅助寻找新型 HIV-1 蛋白酶配体。
Biomolecules. 2023 May 18;13(5):858. doi: 10.3390/biom13050858.
6
Critical Review of Plant-Derived Compounds as Possible Inhibitors of SARS-CoV-2 Proteases: A Comparison with Experimentally Validated Molecules.植物源化合物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白酶潜在抑制剂的批判性综述:与经实验验证的分子的比较
ACS Omega. 2022 Dec 2;7(49):44542-44555. doi: 10.1021/acsomega.2c05766. eCollection 2022 Dec 13.
7
Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma.疫苗、抑制剂、辐射和非热等离子体对抗COVID-19的进展综述
Curr Issues Mol Biol. 2022 Nov 15;44(11):5666-5690. doi: 10.3390/cimb44110384.
8
Mechanistic Insights into the Pharmacological Significance of Silymarin.水飞蓟宾的药理学意义的机制见解。
Molecules. 2022 Aug 21;27(16):5327. doi: 10.3390/molecules27165327.
9
Protein-Ligand Docking in the Machine-Learning Era.蛋白质-配体对接在机器学习时代。
Molecules. 2022 Jul 18;27(14):4568. doi: 10.3390/molecules27144568.
10
Multiplex Technologies in COVID-19 Research, Diagnostics, and Prognostics: Battling the Pandemic.新冠病毒研究、诊断和预后的多重技术:抗击疫情。
Methods Mol Biol. 2022;2511:3-20. doi: 10.1007/978-1-0716-2395-4_1.
运用计算机模拟和体外实验方法鉴定和重新利用抗严重急性呼吸综合征冠状病毒2的抗病毒药物。
Biochem Biophys Res Commun. 2021 Jan 29;538:137-144. doi: 10.1016/j.bbrc.2020.10.094. Epub 2020 Nov 20.
4
History of the COVID-19 pandemic: Origin, explosion, worldwide spreading.COVID-19 大流行的历史:起源、爆发、全球传播。
Biochem Biophys Res Commun. 2021 Jan 29;538:14-23. doi: 10.1016/j.bbrc.2020.10.087. Epub 2020 Nov 6.
5
Spike mutation D614G alters SARS-CoV-2 fitness.刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
6
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19).具有抑制严重急性呼吸综合征冠状病毒2(新冠病毒)潜力的抗严重急性呼吸综合征冠状病毒天然产物。
Front Pharmacol. 2020 Sep 25;11:561334. doi: 10.3389/fphar.2020.561334. eCollection 2020.
7
Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation.通过分子对接、分子动力学模拟和自由能计算对 COVID-19 主蛋白酶抑制剂的合理方法。
Sci Rep. 2020 Oct 19;10(1):17716. doi: 10.1038/s41598-020-74468-0.
8
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.SARS-CoV-2 主蛋白酶的晶体学和亲电片段筛选。
Nat Commun. 2020 Oct 7;11(1):5047. doi: 10.1038/s41467-020-18709-w.
9
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual.一种源自无症状个体的持续复制的 SARS-CoV-2 变体。
J Transl Med. 2020 Sep 23;18(1):362. doi: 10.1186/s12967-020-02535-1.
10
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.博赛泼维与 GC376 均可通过靶向作用于 SARS-CoV-2 的主蛋白酶而有效抑制该病毒。
Nat Commun. 2020 Sep 4;11(1):4417. doi: 10.1038/s41467-020-18233-x.